MAPK/ERK is a signaling pathway from membrane receptors to the nucleus, and PPARγ activated by ROSI will inhibit phosphorylation of ERK, thereby inhibiting the growth of melanoma and breast cancer cells (Liu et al., 2006; Moon et al., 2010). The gene discussed is PPARG; the disease is breast carcinoma.